10 Key 2023 Psychedelic Studies Reveal Optimal Psilocybin Doses for Depression
2023 psychedelic research shows optimal psilocybin dose for depression and the efficacy of psilocybin to treat depression.
Day: December 13, 2023
MDMA-Assisted Therapy for PTSD Edges Toward Acceptance – When Might It Be Approved?
The FDA will have 60 days “to determine whether the MDMA-AT NDA application will be accepted for review and whether it will be a priority or standard review. The estimate timeline is six months or ten months.
End of content
End of content